Accuray Stock Price, News & Analysis (NASDAQ:ARAY)

$5.23 +0.17 (+3.36 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$5.23
Today's Range$5.00 - $5.25
52-Week Range$3.60 - $6.15
Volume559,682 shs
Average Volume1.28 million shs
Market Capitalization$461.10 million
P/E Ratio-18.02
Dividend YieldN/A
Beta1.76

About Accuray (NASDAQ:ARAY)

Accuray logoAccuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Receive ARAY News and Ratings via Email

Sign-up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:ARAY
CUSIP00439710
Phone+1-408-7164600

Debt

Debt-to-Equity Ratio2.66%
Current Ratio1.54%
Quick Ratio0.99%

Price-To-Earnings

Trailing P/E Ratio-18.0172413793103
Forward P/E Ratio-27.50
P/E GrowthN/A

Sales & Book Value

Annual Sales$383.41 million
Price / Sales1.16
Cash FlowN/A
Price / CashN/A
Book Value$0.58 per share
Price / Book9.01

Profitability

Trailing EPS($0.29)
Net Income$-29,570,000.00
Net Margins-6.09%
Return on Equity-44.66%
Return on Assets-5.20%

Miscellaneous

Employees944
Outstanding Shares85,290,000

Accuray (NASDAQ:ARAY) Frequently Asked Questions

What is Accuray's stock symbol?

Accuray trades on the NASDAQ under the ticker symbol "ARAY."

How were Accuray's earnings last quarter?

Accuray Incorporated (NASDAQ:ARAY) posted its quarterly earnings data on Tuesday, January, 23rd. The medical equipment provider reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.05. The medical equipment provider earned $100.33 million during the quarter, compared to analyst estimates of $90.31 million. Accuray had a negative net margin of 6.09% and a negative return on equity of 44.66%. The company's revenue was up 14.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.11) EPS. View Accuray's Earnings History.

When will Accuray make its next earnings announcement?

Accuray is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Accuray.

Where is Accuray's stock going? Where will Accuray's stock price be in 2018?

7 brokerages have issued 12 month price targets for Accuray's shares. Their predictions range from $6.00 to $10.00. On average, they anticipate Accuray's share price to reach $7.40 in the next year. View Analyst Ratings for Accuray.

Who are some of Accuray's key competitors?

Who are Accuray's key executives?

Accuray's management team includes the folowing people:

  • Louis J. Lavigne Jr., Independent Chairperson of the Board (Age 69)
  • Joshua H. Levine, President, Chief Executive Officer, Director (Age 53)
  • Elizabeth H. Davila, Independent Vice Chairperson of the Board (Age 73)
  • Kevin Waters, Chief Financial Officer, Senior Vice President (Age 40)
  • Alaleh Nouri, Senior Vice President, General Counsel, Corporate Secretary (Age 38)
  • Lionel Hadjadjeba, Senior Vice President, Chief Commercial Officer (Age 58)
  • Andy Kirkpatrick, Senior Vice President - Global Operations (Age 54)
  • Shig Hamamatsu, Vice President, Finance and Chief Accounting Officer, Principal Accounting Officer
  • Beverly A. Huss, Director (Age 57)
  • Jack Goldstein Ph.D., Independent Director (Age 70)

Who owns Accuray stock?

Accuray's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.62%), Renaissance Technologies LLC (5.34%), Heartland Advisors Inc. (4.05%), Millennium Management LLC (3.41%), Vident Investment Advisory LLC (3.00%) and Royce & Associates LP (2.18%). Company insiders that own Accuray stock include Alaleh Nouri, Joshua Levine, Kelly Londy and Kevin Waters. View Institutional Ownership Trends for Accuray.

Who sold Accuray stock? Who is selling Accuray stock?

Accuray's stock was sold by a variety of institutional investors in the last quarter, including Vident Investment Advisory LLC, Millennium Management LLC, Lapides Asset Management LLC, Sectoral Asset Management Inc, Metropolitan Life Insurance Co. NY and Rhumbline Advisers. Company insiders that have sold Accuray company stock in the last year include Alaleh Nouri, Joshua Levine, Kelly Londy and Kevin Waters. View Insider Buying and Selling for Accuray.

Who bought Accuray stock? Who is buying Accuray stock?

Accuray's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Global X Management Co. LLC, Heartland Advisors Inc., Bogle Investment Management L P DE, Alambic Investment Management L.P., Renaissance Technologies LLC, Two Sigma Investments LP and Adirondack Research & Management Inc.. View Insider Buying and Selling for Accuray.

How do I buy Accuray stock?

Shares of Accuray can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Accuray's stock price today?

One share of Accuray stock can currently be purchased for approximately $5.23.

How big of a company is Accuray?

Accuray has a market capitalization of $461.10 million and generates $383.41 million in revenue each year. The medical equipment provider earns $-29,570,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis. Accuray employs 944 workers across the globe.

How can I contact Accuray?

Accuray's mailing address is 1310 Chesapeake Ter, SUNNYVALE, CA 94089-1100, United States. The medical equipment provider can be reached via phone at +1-408-7164600 or via email at [email protected]


MarketBeat Community Rating for Accuray (ARAY)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  213 (Vote Outperform)
Underperform Votes:  175 (Vote Underperform)
Total Votes:  388
MarketBeat's community ratings are surveys of what our community members think about Accuray and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Accuray (NASDAQ:ARAY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.432.432.502.50
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.40$7.33$6.60$6.60
Price Target Upside: 35.78% upside34.56% upside45.05% upside60.98% upside

Accuray (NASDAQ:ARAY) Consensus Price Target History

Price Target History for Accuray (NASDAQ:ARAY)

Accuray (NASDAQ:ARAY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/24/2018Royal Bank of CanadaSet Price TargetHold$6.00MediumView Rating Details
12/13/2017JPMorgan Chase & Co.DowngradeNeutral -> Underweight$6.00HighView Rating Details
11/30/2017Lake Street CapitalInitiated CoverageBuy -> Buy$10.00HighView Rating Details
10/27/2017CowenReiterated RatingBuy$9.00N/AView Rating Details
8/24/2017BTIG ResearchReiterated RatingHoldMediumView Rating Details
8/23/2017Jefferies GroupLower Price TargetBuy$7.00 -> $6.00LowView Rating Details
3/21/2017AegisReiterated RatingBuyMediumView Rating Details
8/18/2016Morgan StanleySet Price TargetHold$8.00N/AView Rating Details
5/22/2016Brean CapitalReiterated RatingBuy$12.00N/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Accuray (NASDAQ:ARAY) Earnings History and Estimates Chart

Earnings by Quarter for Accuray (NASDAQ:ARAY)

Accuray (NASDAQ ARAY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018($0.05)N/AView Earnings Details
1/23/2018Q2 18($0.11)($0.06)$90.31 million$100.33 millionViewListenView Earnings Details
10/24/2017Q1 2018($0.09)($0.07)$88.26 million$91.00 millionViewN/AView Earnings Details
8/22/20176/30/2017($0.01)($0.06)$112.00 million$112.09 millionViewN/AView Earnings Details
4/27/2017Q3 2017$0.01($0.06)$110.23 million$97.31 millionViewN/AView Earnings Details
1/31/2017Q217($0.09)($0.11)$93.74 million$87.50 millionViewListenView Earnings Details
10/27/2016Q117($0.10)($0.12)$37.34 million$86.50 millionViewListenView Earnings Details
8/17/2016Q316($0.07)($0.09)$98.97 million$95.00 millionViewListenView Earnings Details
4/26/2016Q316($0.06)$0.01$102.79 million$105.30 millionViewListenView Earnings Details
1/28/2016Q216($0.08)($0.08)$101.15 million$108.90 millionViewListenView Earnings Details
10/29/2015Q116($0.14)($0.12)$88.60 million$89.60 millionViewListenView Earnings Details
8/20/2015Q415($0.04)($0.07)$102.41 million$101.80 millionViewListenView Earnings Details
4/30/2015Q315($0.06)($0.04)$102.72 million$97.50 millionViewListenView Earnings Details
1/27/2015Q215($0.08)($0.13)$98.87 million$98.20 millionViewListenView Earnings Details
10/29/2014Q115($0.13)($0.28)$88.90 million$82.40 millionViewListenView Earnings Details
8/21/2014Q414($0.07)($0.13)$92.23 million$102.00 millionViewListenView Earnings Details
4/30/2014Q314($0.16)($0.06)$82.00 million$97.10 millionViewListenView Earnings Details
1/30/2014Q214($0.20)($0.07)$80.20 million$93.60 millionViewListenView Earnings Details
11/7/2013Q114($0.20)($0.21)$79.67 million$76.60 millionViewListenView Earnings Details
8/27/2013Q4 2013($0.20)($0.20)$82.29 million$84.90 millionViewListenView Earnings Details
5/7/2013Q3 2013($0.22)($0.37)$77.97 million$70.55 millionViewListenView Earnings Details
2/6/2013Q2 2013($0.33)($0.30)$74.23 million$77.80 millionViewListenView Earnings Details
11/7/2012Q113($0.22)($0.23)$85.41 million$83.00 millionViewN/AView Earnings Details
9/6/2012Q412($0.12)($0.20)$106.92 million$100.50 millionViewN/AView Earnings Details
5/8/2012($0.14)($0.21)ViewN/AView Earnings Details
2/8/2012Q2 2012($0.19)($0.10)ViewN/AView Earnings Details
11/8/2011($0.29)($0.38)ViewN/AView Earnings Details
9/19/2011$0.02($0.40)ViewN/AView Earnings Details
5/5/2011$0.04($0.02)ViewN/AView Earnings Details
1/27/2011($0.01)$0.07ViewN/AView Earnings Details
11/8/2010Q1 2011($0.07)($0.08)ViewN/AView Earnings Details
8/31/2010Q4 2010$0.05$0.08ViewN/AView Earnings Details
5/6/2010Q3 2010$0.01$0.04ViewN/AView Earnings Details
2/4/2010Q2 2010($0.01)($0.02)ViewN/AView Earnings Details
10/29/2009Q1 2010($0.03)($0.06)ViewN/AView Earnings Details
8/24/2009Q4 2009$0.03$0.02ViewN/AView Earnings Details
5/5/2009Q3 2009$0.02$0.05ViewN/AView Earnings Details
1/29/2009Q2 2009$0.02$0.02ViewN/AView Earnings Details
12/18/2008Q1 2009$0.02($0.06)ViewN/AView Earnings Details
4/29/2008Q3 2008$0.05$0.01ViewN/AView Earnings Details
1/30/2008Q2 2008$0.12$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Accuray (NASDAQ:ARAY) Earnings Estimates

2018 EPS Consensus Estimate: ($0.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.04)($0.04)($0.04)
Q2 20181($0.10)($0.10)($0.10)
Q3 20181($0.04)($0.04)($0.04)
Q4 20181$0.01$0.01$0.01
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Accuray (NASDAQ:ARAY)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Accuray (NASDAQ ARAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.90%
Institutional Ownership Percentage: 84.99%
Insider Trades by Quarter for Accuray (NASDAQ:ARAY)
Institutional Ownership by Quarter for Accuray (NASDAQ:ARAY)

Accuray (NASDAQ ARAY) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2017Alaleh NouriSVPSell2,166$4.86$10,526.76207,068View SEC Filing  
12/1/2017Joshua LevineCEOSell17,093$4.86$83,071.981,435,428View SEC Filing  
12/1/2017Kevin WatersCFOSell7,154$5.06$36,199.24335,087View SEC Filing  
10/4/2017Kelly LondyCOOSell99,136$4.24$420,336.64View SEC Filing  
11/9/2015Joshua LevineCEOBuy50,000$7.12$356,000.001,115,830View SEC Filing  
2/2/2015Alaleh NouriSVPSell5,164$7.38$38,110.32View SEC Filing  
11/30/2014Alaleh NouriSVPSell268$6.62$1,774.16View SEC Filing  
11/30/2014Kelly LondyEVPSell2,273$6.62$15,047.26View SEC Filing  
11/3/2014Joshua LevineCEOBuy100,000$6.34$634,000.00View SEC Filing  
5/6/2014Joshua LevineCEOBuy50,000$8.15$407,500.00531,210View SEC Filing  
2/4/2014Richard PettingillDirectorBuy9,795$10.33$101,182.3543,940View SEC Filing  
12/4/2013Jack GoldsteinDirectorSell7,000$7.70$53,900.0066,237View SEC Filing  
12/3/2013Elizabeth DavilaDirectorSell8,000$7.74$61,920.0077,137View SEC Filing  
9/4/2013Darren J MillikenSVPSell11,002$6.53$71,843.06View SEC Filing  
3/5/2013Dennis L WingerDirectorBuy20,000$4.30$86,000.00View SEC Filing  
2/13/2013Joshua LevineCEOBuy100,000$4.38$438,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Accuray (NASDAQ ARAY) News Headlines

Source:
DateHeadline
Accuray (ARAY) Presents At RBC Capital Markets Global Healthcare Conference - SlideshowAccuray (ARAY) Presents At RBC Capital Markets Global Healthcare Conference - Slideshow
seekingalpha.com - February 23 at 5:15 PM
Why Is Accuray (ARAY) Down 8% Since its Last Earnings Report?Why Is Accuray (ARAY) Down 8% Since its Last Earnings Report?
finance.yahoo.com - February 22 at 5:06 PM
Accuray (ARAY) Downgraded by Zacks Investment Research to "Hold"Accuray (ARAY) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - February 22 at 1:08 PM
Zacks Investment Research Upgrades Accuray (ARAY) to "Buy"Zacks Investment Research Upgrades Accuray (ARAY) to "Buy"
www.americanbankingnews.com - February 21 at 2:34 PM
Accurays European AERO Academy Meeting: Innovation and Safety in the Field of Advanced Radiotherapy - Patients Come FirstAccuray's European AERO Academy Meeting: Innovation and Safety in the Field of Advanced Radiotherapy - Patients Come First
www.finanznachrichten.de - February 20 at 8:50 AM
Accuray to Present at the 2018 RBC Capital Markets Global Healthcare Conference on February 22, 2018Accuray to Present at the 2018 RBC Capital Markets Global Healthcare Conference on February 22, 2018
finance.yahoo.com - February 15 at 4:50 PM
Zacks Investment Research Lowers Accuray (ARAY) to HoldZacks Investment Research Lowers Accuray (ARAY) to Hold
www.americanbankingnews.com - February 14 at 12:58 PM
Accuray (ARAY) Upgraded at Zacks Investment ResearchAccuray (ARAY) Upgraded at Zacks Investment Research
www.americanbankingnews.com - February 13 at 5:54 PM
BidaskClub Lowers Accuray (ARAY) to HoldBidaskClub Lowers Accuray (ARAY) to Hold
www.americanbankingnews.com - February 11 at 10:16 PM
Accuray Incorporated (ARAY) Expected to Post Quarterly Sales of $98.18 MillionAccuray Incorporated (ARAY) Expected to Post Quarterly Sales of $98.18 Million
www.americanbankingnews.com - February 10 at 6:16 AM
Accuray Incorporated (ARAY) Expected to Post Earnings of -$0.03 Per ShareAccuray Incorporated (ARAY) Expected to Post Earnings of -$0.03 Per Share
www.americanbankingnews.com - February 8 at 9:22 PM
Accuray (ARAY) Stock Rating Upgraded by Zacks Investment ResearchAccuray (ARAY) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - February 5 at 3:52 PM
Accuray Retires February 2018 Convertible NotesAccuray Retires February 2018 Convertible Notes
www.prnewswire.com - February 5 at 7:10 AM
Accuray Incorporated (ARAY) Given Average Recommendation of "Buy" by BrokeragesAccuray Incorporated (ARAY) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 2 at 9:08 AM
4 Reasons Why You Should Buy Accuray (ARAY) Stock Right Now4 Reasons Why You Should Buy Accuray (ARAY) Stock Right Now
www.zacks.com - February 1 at 9:28 AM
Illumina (ILMN) Tops Q4 Earnings & Revenues, Issues GuidanceIllumina (ILMN) Tops Q4 Earnings & Revenues, Issues Guidance
finance.yahoo.com - January 31 at 9:47 AM
Align Technology (ALGN) Q4 Earnings Top on Invisalign SalesAlign Technology (ALGN) Q4 Earnings Top on Invisalign Sales
finance.yahoo.com - January 31 at 9:47 AM
Stryker (SYK) Beats Earnings and Revenue Estimates in Q4Stryker (SYK) Beats Earnings and Revenue Estimates in Q4
finance.yahoo.com - January 31 at 9:47 AM
Study Shows CyberKnife® System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia PatientsStudy Shows CyberKnife® System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia Patients
finance.yahoo.com - January 29 at 9:35 AM
Accuray (ARAY) Stock Rating Upgraded by BidaskClubAccuray (ARAY) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - January 27 at 10:16 AM
Zacks Investment Research Upgrades Accuray (ARAY) to BuyZacks Investment Research Upgrades Accuray (ARAY) to Buy
www.americanbankingnews.com - January 26 at 8:38 PM
Brokers Offer Predictions for Accuray Incorporateds Q3 2018 Earnings (ARAY)Brokers Offer Predictions for Accuray Incorporated's Q3 2018 Earnings (ARAY)
www.americanbankingnews.com - January 26 at 10:22 AM
Free Post Earnings Research Report: Accuray’s Revenue Advanced 15%; Net Loss NarrowedFree Post Earnings Research Report: Accuray’s Revenue Advanced 15%; Net Loss Narrowed
finance.yahoo.com - January 26 at 9:31 AM
Royal Bank of Canada Reiterates "$6.00" Price Target for Accuray (ARAY)Royal Bank of Canada Reiterates "$6.00" Price Target for Accuray (ARAY)
www.americanbankingnews.com - January 24 at 10:50 PM
Accuray Fiscal Second Quarter Revenue Exceeds $100 Million and Increases 15 Percent Year-over-Year; Gross Orders of $77.9 Million; Backlog Up 10 PercentAccuray Fiscal Second Quarter Revenue Exceeds $100 Million and Increases 15 Percent Year-over-Year; Gross Orders of $77.9 Million; Backlog Up 10 Percent
finance.yahoo.com - January 24 at 9:56 AM
Accuray Incorporated (ARAY) Expected to Announce Quarterly Sales of $91.29 MillionAccuray Incorporated (ARAY) Expected to Announce Quarterly Sales of $91.29 Million
www.americanbankingnews.com - January 24 at 4:46 AM
Accuray (ARAY) Releases  Earnings ResultsAccuray (ARAY) Releases Earnings Results
www.americanbankingnews.com - January 23 at 9:22 PM
-$0.11 Earnings Per Share Expected for Accuray Incorporated (ARAY) This Quarter-$0.11 Earnings Per Share Expected for Accuray Incorporated (ARAY) This Quarter
www.americanbankingnews.com - January 22 at 9:08 PM
Analyst Recommendations for Varian Medical Systems before 1Q18Analyst Recommendations for Varian Medical Systems before 1Q18
finance.yahoo.com - January 19 at 3:15 PM
Accuray (ARAY) to Release Quarterly Earnings on TuesdayAccuray (ARAY) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - January 16 at 3:50 AM
Beverly A. Huss Joins Accuray Board of Directors - PR Newswire - PR Newswire (press release)Beverly A. Huss Joins Accuray Board of Directors - PR Newswire - PR Newswire (press release)
www.prnewswire.com - January 12 at 5:01 AM
Accuray To Report Fiscal 2018 Second Quarter Financial Results On January 23, 2018Accuray To Report Fiscal 2018 Second Quarter Financial Results On January 23, 2018
finance.yahoo.com - January 10 at 3:15 PM
Accuray To Report Fiscal 2018 Second Quarter Financial Results On January 23, 2018Accuray To Report Fiscal 2018 Second Quarter Financial Results On January 23, 2018
finance.yahoo.com - January 10 at 3:15 PM
Accuray Incorporated (ARAY) Receives Consensus Rating of "Hold" from AnalystsAccuray Incorporated (ARAY) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - January 8 at 6:02 AM
$91.29 Million in Sales Expected for Accuray Incorporated (ARAY) This Quarter$91.29 Million in Sales Expected for Accuray Incorporated (ARAY) This Quarter
www.americanbankingnews.com - January 7 at 3:40 AM
Accuray to Present at the 36th Annual JP Morgan Healthcare Conference on January 10, 2018 - PR Newswire (press release)Accuray to Present at the 36th Annual JP Morgan Healthcare Conference on January 10, 2018 - PR Newswire (press release)
www.prnewswire.com - January 4 at 5:19 AM
Accuray Elects Net Share Settlement for 3.50% Series A Convertible ... - PR Newswire (press release)Accuray Elects Net Share Settlement for 3.50% Series A Convertible ... - PR Newswire (press release)
www.prnewswire.com - January 4 at 5:19 AM
Accuray Elects Net Share Settlement for 3.50% Series A Convertible Senior Notes Due 2018Accuray Elects Net Share Settlement for 3.50% Series A Convertible Senior Notes Due 2018
finance.yahoo.com - January 4 at 5:19 AM
Accuray to Present at the 36th Annual J.P. Morgan Healthcare Conference on January 10, 2018Accuray to Present at the 36th Annual J.P. Morgan Healthcare Conference on January 10, 2018
finance.yahoo.com - January 3 at 11:23 AM
-$0.11 EPS Expected for Accuray Incorporated (ARAY) This Quarter-$0.11 EPS Expected for Accuray Incorporated (ARAY) This Quarter
www.americanbankingnews.com - December 20 at 7:10 AM
Accuray (ARAY) Rating Lowered to Hold at BidaskClubAccuray (ARAY) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - December 17 at 6:34 PM
Accuray, Inc. – Value Analysis (NASDAQ:ARAY) : December 15, 2017Accuray, Inc. – Value Analysis (NASDAQ:ARAY) : December 15, 2017
finance.yahoo.com - December 15 at 3:15 PM
Contrasting ArthroCare (ARTC) & Accuray (ARAY)Contrasting ArthroCare (ARTC) & Accuray (ARAY)
www.americanbankingnews.com - December 15 at 3:10 AM
First Hospitals in the World Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms - PR Newswire (press release)First Hospitals in the World Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms - PR Newswire (press release)
www.prnewswire.com - December 14 at 3:15 PM
Accuray, Inc. breached its 50 day moving average in a Bearish Manner : ARAY-US : December 14, 2017Accuray, Inc. breached its 50 day moving average in a Bearish Manner : ARAY-US : December 14, 2017
finance.yahoo.com - December 14 at 3:15 PM
Accuray (ARAY) and Invivo Therapeutics (NVIV) Critical ContrastAccuray (ARAY) and Invivo Therapeutics (NVIV) Critical Contrast
www.americanbankingnews.com - December 14 at 9:52 AM
First Hospitals in the World Achieve Inter-System Connectivity Across Accuray Radiation Therapy PlatformsFirst Hospitals in the World Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
www.prnewswire.com - December 14 at 7:52 AM
Accuray Incorporated (ARAY) Receives Average Recommendation of "Hold" from AnalystsAccuray Incorporated (ARAY) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 14 at 5:48 AM
Accuray Incorporated (ARAY) Short Interest Up 22.6% in NovemberAccuray Incorporated (ARAY) Short Interest Up 22.6% in November
www.americanbankingnews.com - December 14 at 3:10 AM
Accuray (ARAY) Rating Lowered to Underweight at J P Morgan Chase & CoAccuray (ARAY) Rating Lowered to Underweight at J P Morgan Chase & Co
www.americanbankingnews.com - December 13 at 11:10 PM

SEC Filings

Accuray (NASDAQ:ARAY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Accuray (NASDAQ:ARAY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Accuray (NASDAQ ARAY) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.